Welcome to the ValueWiki PRO (PRW) article! Register for free or click the "edit" link to contribute!    

PRO (PRW)

From ValueWiki

Jump to: navigation, search
This summary section needs content! Click Here to begin writing.
Have a question about PRO? Ask it on the Message Board or Chat Room
Visit the Apple, Inc. page for an example of a complete article.

Contents

Today 5d 3m 6m 1y 2y 5y Max





Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.[1] Be bold!

News Feed

11/20/08 7:11 am PRO PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)
11/20/08 7:11 am Pro-Pharmaceuticals Files Registration Statement for Rights Offering to Its Shareholders (Business Wire)
11/14/08 7:11 am Pro-Pharmaceuticals to Commence Rights Offering to Shareholders (Business Wire)
11/13/08 4:11 pm PRO PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta (EDGAR Online)
11/13/08 4:11 pm Pro-Pharmaceuticals Receives Delisting Notice from NYSE Alternext US (Business Wire)
11/07/08 7:11 am PRO PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E (EDGAR Online)
11/07/08 7:11 am Pro-Pharmaceuticals Reports Third Quarter Results (Business Wire)
11/07/08 7:11 am PRO PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
11/06/08 7:11 am Pro-Pharmaceuticals to Present Corporate Update at the Rodman & Renshaw Annual Global Investment Conference (Business Wire)
10/06/08 6:10 am Pro-Pharmaceuticals' Pre-NDA Meeting Scheduled with FDA (Business Wire)
More News...

Risks

This section needs content! Click the blue edit link (to the right) to contribute.

Research Links

PRO Snapshot
PRO Leadership
PRO Fundamentals
PRO Technical Analysis
PRO Message Boards

Notes

  1. This is a sample reference.
Personal tools